High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC

Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations did not observe an improvement of patient’s outcome. The aim...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Montaudon, Elodie, El Botty, Rania, Vacher, Sophie, Déas, Olivier, Naguez, Adnan, Chateau-Joubert, Sophie, Treguer, Damien, de Plater, Ludmilla, Zemoura, Leïla, Némati, Fariba, Nicolas, André, Chapelier, Alain, Livartowski, Alain, Cairo, Stefano, Daniel, Catherine, Brevet, Marie, Marangoni, Elisabetta, Meseure, Didier, Roman-Roman, Sergio, Bieche, Ivan, Girard, Nicolas, Decaudin, Didier
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2021
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8057272/
https://ncbi.nlm.nih.gov/pubmed/33889306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27930
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker